Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03939026
Title Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma (ALPHA)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Allogene Therapeutics
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center Gilbert Arizona 85234 United States Details
University of California, Los Angeles Los Angeles California 90095 United States Details
Stanford University Stanford California 94305 United States Details
Colorado Blood Cancer Institute Denver Colorado 80218 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Norton Cancer Institute Louisville Kentucky 40207 United States Details
St. Davids South Austin Medical Center Austin Texas 78704 United States Details
MD Anderson Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from for the field